Closed 3D Liver Microtissues for iPSC Hepatocyte Maturation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing liver microtissue from induced pluripotent stem cells are complex, costly, and difficult to scale up, resulting in insufficient functional hepatocyte production and integration, limiting their use in treating liver failure.
Innovation Solution
A three-dimensional liver microtissue comprising at least three different phenotypes of liver cells, including immature and mature hepatocytes, cholangiocytes, and mesenchymal stem cells, encapsulated in a single closed microcompartment, which replicates the liver microenvironment for improved integration and functionality.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If guided differentiation protocols are used to produce hepatocytes from pluripotent stem cells, then an almost inexhaustible source of hepatocytes is obtained, but the production cost is very high (around 9.7 million dollars for autologous liver grafts) and the cells retain fetal liver characteristics with low functional maturity
Solution Approach 1:
The invention segments the liver tissue into microtissues containing 10-100 cells each, encapsulated in separate microcompartments. This segmentation allows independent cultivation and differentiation of each microtissue unit, reducing overall production costs while maintaining functional maturity through controlled microenvironment development.
Solution Approach 2:
The invention changes the cultivation parameters by using 3D microcompartment encapsulation instead of traditional 2D culture, and by controlling the microenvironmental parameters (oxygen tension, nutrient diffusion, cell density) within each microtissue to promote functional maturation and reduce production costs.
2Adaptability or versatility
If isolated hepatocytes are transplanted to treat liver failure, then a large number of patients can be treated, but the hepatocytes show poor survival, integration and expansion in vivo, limiting therapeutic effects
Solution Approach 1:
The invention nests multiple hepatocytes and supporting cell types within a single encapsulated microcompartment, creating a self-contained unit that mimics the native liver microenvironment. This nested structure protects the cells during transplantation and promotes their survival and integration in the host liver.
Solution Approach 2:
The invention performs preliminary differentiation and maturation of hepatocytes within the microcompartment before transplantation, allowing cells to develop functional maturity and integration capabilities in advance. This preliminary action ensures better survival and functionality after implantation in the host.
3Quantity of substance
If primary hepatocytes are cultured in vitro, then hepatocyte production is achieved, but the cells undergo dedifferentiation, decreasing the number of mature hepatocytes and reducing therapeutic quality
Solution Approach 1:
The invention creates different local microenvironments within the microcompartment that promote functional maturation. By controlling local conditions such as oxygen tension, nutrient gradients, and cell-cell interactions, the microtissue maintains high hepatocyte maturity and functionality throughout the cultivation process.
Solution Approach 2:
The invention uses composite microcompartment structures combining hydrogel matrices with embedded cells, creating a multi-component system that supports both proliferation and maturation of hepatocytes while preventing dedifferentiation.
4Reliability
If complex protocols with dissociation and reaggregation steps are used, then functional hepatocyte characteristics are obtained, but the protocol complexity increases, adding risks and increasing total cost
Solution Approach 1:
The invention extracts and eliminates unnecessary intermediate steps such as dissociation and reaggregation by using direct encapsulation and differentiation of pluripotent stem cells into functional hepatocytes within the microcompartment. This simplification reduces protocol complexity while maintaining functional characteristics.
Solution Approach 2:
The microcompartment system enables self-organization and self-differentiation of cells without requiring complex external manipulation. The encapsulated cells automatically organize into functional microtissues through inherent biological programs, eliminating the need for人工 dissociation and reaggregation steps.
Data Source
AI summary
The invention relates to a specific liver microtissue comprising at least 3 different phenotypes of hepatocytes obtained from induced pluripotent stem cells encapsulated in a single three-dimensionally closed microcompartment. The invention also relates to a method for preparing such a liver microtissue and the uses thereof in the treatment or prevention of liver failure.